Pharma Stocks
-
Market Watchlist: Critical week for tech stocks; will pharma & realty keep Nifty above 25,400? – Stock Insights News
We had gone in last week pencilling in the potential for large moves, with a likely upside objective of 25,400-25,600.…
Read More » -
Teva (NYSE:TEVA): Is the Market Overlooking This Pharma Giant’s True Value?
If you have been watching Teva Pharmaceutical Industries (NYSE:TEVA) lately, you might have noticed that the stock has struggled to…
Read More » -
How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals’ (JAZZ) Rare Oncology Expansion
Earlier this month, Jazz Pharmaceuticals announced that Modeyso (dordaviprone) was recommended by the National Comprehensive Cancer Network (NCCN) Guidelines as…
Read More » -
Did Takeda’s (TSE:4502) Positive Narcolepsy Data and Executive Moves Just Shift Its Investment Narrative?
Takeda announced positive Phase 3 results for oveporexton, its investigational therapy for narcolepsy type 1, and highlighted key executive leadership…
Read More » -
Sumitomo Pharma (TSE:4506): Evaluating Valuation After Recent Strong Share Price Surge
Sumitomo Pharma (TSE:4506) has piqued investor curiosity lately as its stock showed an impressive surge in recent weeks, despite there…
Read More » -
Opendoor Stock Shorted by ‘Pharma Bro’ Martin Shkreli
Martin Shkreli has returned. First rising to fame as the “pharma bro” who jacked up the price of an AIDS…
Read More » -
Ahead of Market: 10 things that will decide D-Street action on Monday
The Indian market ended lower on Friday, with the Sensex and Nifty snapping a three-day winning streak that had been…
Read More » -
Stoxx 600, FTSE, DAX, BOE decision
The Bank of England (BOE) in the City of London, UK, on Monday, Dec. 16, 2024. Jason Alden | Bloomberg…
Read More » -
HCL Tech, HDFC Bank, Sun Pharma, Tata Motors stocks rise on US Fed rate cut
The other stocks made significant gain in the Indian markets on the day include MOIL, Cochin Shipyard, Avenue Supermarts. Shares…
Read More » -
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed
CUPERTINO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage…
Read More »